Lamberg B A, Pelkonen R, Aro A, Grahne B
Acta Endocrinol (Copenh). 1976 Jun;82(2):254-66. doi: 10.1530/acta.0.0820254.
Thyroid function was studied in acromegaly before and after transsphenoidal hypophysectomy followed by cryoapplication. The clinical material comprised 36 euthyroid, 1 hypothyroid and 3 hyperthyroid patients. In addition to the usual thyroid parameters a standard thyrotrophin-releasing hormone (TRH) stimulation test using 200 mug of synthetic TRH given iv was used. In untreated acromegaly with euthyroidism the response of serum TSH to TRH was significantly less than in normal controls, the increment being 7.1 mU/1 vs. 12.5 mU/1. In 23% of the patients the response was subnormal (less than 3.0 mU/1). The total thyroxine was significantly higher than in controls. Goitre occurred in 53% of the patients. After operation 3 patients became hypothyroid. In 30% of the patients remaining euthyroid the response to TRH was subnormal and the mean response in this group was close to the lower normal limit of 3.0 mU/1. In 7 patients who showed a subnormal response to TRH before or shortly after the operation there was a gradual increase and normalization of the response during the next few years. A subnormal, and also a low normal response to TRH before or after hypophysectomy does not necessarily indicate an increased risk for the development of hypothyroidism, and indeed the pituitary remnant seems to have a remarkable capacity for regeneration. In the hypothyroid patient there was a low normal response to TRH, the reason being unknown. In one of the hyperthyroid patients the basal TSH level was 6.5 and 8.9 mU/1 on two occasions in the thyrotoxic phase, showing a small response to TRH. The possibility that hyperthyroidism was due to increased secretion of TSH is discussed but not claimed proven. The incidence of hyperthyroidism in a large material of acromegaly from this department equals 9% which is above the prevalence of hyperthyroidism in the general population in Finland, indicating that acromegaly in one way or another seems to increase the incidence of manifest thyrotoxicosis.
对肢端肥大症患者在经蝶窦垂体切除术加冷冻治疗前后的甲状腺功能进行了研究。临床资料包括36例甲状腺功能正常、1例甲状腺功能减退和3例甲状腺功能亢进的患者。除了常规的甲状腺参数外,还采用了静脉注射200微克合成促甲状腺激素释放激素(TRH)的标准TRH刺激试验。在未经治疗的甲状腺功能正常的肢端肥大症患者中,血清促甲状腺激素(TSH)对TRH的反应明显低于正常对照组,增加值分别为7.1 mU/1和12.5 mU/1。23%的患者反应低于正常水平(低于3.0 mU/1)。总甲状腺素明显高于对照组。53%的患者出现甲状腺肿大。术后3例患者出现甲状腺功能减退。在其余甲状腺功能正常的患者中,30%对TRH的反应低于正常水平,该组的平均反应接近3.0 mU/1的正常下限。在7例术前或术后不久对TRH反应低于正常水平的患者中,在接下来的几年里反应逐渐增加并恢复正常。垂体切除术前或术后对TRH反应低于正常水平以及反应处于正常低限并不一定表明发生甲状腺功能减退的风险增加,实际上垂体残余似乎具有显著的再生能力。在甲状腺功能减退的患者中,对TRH的反应处于正常低限,原因不明。在1例甲状腺功能亢进患者中,在甲状腺毒症期两次测得基础TSH水平分别为6.5和8.9 mU/1,对TRH反应较小。文中讨论了甲状腺功能亢进可能是由于TSH分泌增加所致,但未证实。该科室大量肢端肥大症患者中甲状腺功能亢进的发生率为9%,高于芬兰普通人群中甲状腺功能亢进的患病率,这表明肢端肥大症似乎以某种方式增加了显性甲状腺毒症的发生率。